{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-25-000111","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2025-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.446521+00:00","generated_at":"2026-05-18T05:54:44.811185+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elevance Health cuts FY2025 adjusted EPS guidance to ~$30 on elevated medical costs","bullets":["Operating revenue $49.4B (+14.3% YoY); diluted EPS $7.72, adjusted diluted EPS $8.84.","Benefit expense ratio 88.9% (+260 bps) reflecting higher medical costs in Medicaid and ACA.","FY2025 GAAP EPS guidance ~$24.10; adjusted EPS guidance ~$30.00 (previously ~$35).","Health Benefits segment operating gain $1.6B vs $2.1B prior year; margin 3.8% vs 5.8%.","Returned $2.0B of capital to shareholders YTD; declared $1.71/quarter dividend payable 9/25/25."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-25-000111","json":"https://secwatch.observer/filing/0001156039-25-000111.json","markdown":"https://secwatch.observer/filing/0001156039-25-000111.md","text":"https://secwatch.observer/filing/0001156039-25-000111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/0001156039-25-000111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603925000111/elv-20250717.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T05:54:44.811185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}